Royal visit to celebrate key role in vaccine development

Malvern Panalytical, experts in high-precision analytical instruments, welcomed His Royal Highness The Earl of Wessex, Prince Edward, to its Worcestershire headquarters. Malvern Panalytical was selected for the Royal visit, amongst a small number of other Worcestershire businesses, primarily because of its scientific and technical contribution to the development of medicines and vaccines to treat and prevent Covid-19.

Andrew Heath, Chief Executive of Spectris, said: “It has been our pleasure to welcome Prince Edward to our Malvern development and manufacturing facility today and to explain how Malvern Panalytical’s people, products and services are assisting the global effort to fight Covid-19. We are immensely proud of the role the team here is playing in applying its technical and scientific expertise to help alleviate this humanitarian crisis.”

His Royal Highness was introduced to Malvern Panalytical employees from across the business during his walk through the facility, learning about the roles they play in the development of new technologies and services. Also on display were the scientific instruments used by Malvern Panalytical’s pharmaceutical customers in developing and manufacturing new drugs and vaccines.

Mark Fleiner – President, Malvern Panalytical, commented: “Malvern Panalytical provides the instruments and expertise to support robust and rapid vaccine development and assist pharmaceutical organisations in assuring the quality of vaccines and other treatments.”

Related Articles

Join FREE today and become a member
of Drug Discovery World

Membership includes:

  • Full access to the website including free and gated premium content in news, articles, business, regulatory, cancer research, intelligence and more.
  • Unlimited App access: current and archived digital issues of DDW magazine with search functionality, special in App only content and links to the latest industry news and information.
  • Weekly e-newsletter, a round-up of the most interesting and pertinent industry news and developments.
  • Whitepapers, eBooks and information from trusted third parties.
Join For Free